Carvedilol and Abdominal adhesions - a phase IV clinical study of FDA data

Summary:

Abdominal adhesions is found among people who take Carvedilol, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Carvedilol and have Abdominal adhesions. It is created by eHealthMe based on reports of 95,214 people who have side effects when taking Carvedilol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 03, 2023

95,214 people reported to have side effects when taking Carvedilol.
Among them, 29 people (0.03%) have Abdominal adhesions.

What is Carvedilol?

Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 97,395 Carvedilol users for its effectiveness, alternative drugs and more.

What is Abdominal adhesions?

Abdominal adhesions (inflammation of abdomen) is found to be associated with 1,333 drugs and 894 conditions by eHealthMe.

Number of Carvedilol and Abdominal adhesions reports submitted per year:

Could Carvedilol cause Abdominal adhesions?

Gender of people who have Abdominal adhesions when taking Carvedilol *:

female: 65.52 %
male: 34.48 %

Age of people who have Abdominal adhesions when taking Carvedilol *:

Common drugs people take besides Carvedilol *:

Common side effects people have besides Abdominal adhesions *:

Intestinal Obstruction: 12 people, 41.38%
Nausea (feeling of having an urge to vomit): 10 people, 34.48%
Memory Loss: 9 people, 31.03%
Weight Decreased: 8 people, 27.59%
Fall: 8 people, 27.59%
Headache (pain in head): 7 people, 24.14%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 24.14%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 24.14%
Ejection Fraction Decreased (systolic heart failure): 7 people, 24.14%
Weight Increased: 7 people, 24.14%

Common conditions people have *:

Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 14 people, 48.28%
High Blood Cholesterol: 12 people, 41.38%
Sleep Disorder: 8 people, 27.59%
Cardiac Disorder: 7 people, 24.14%
Neuroendocrine Tumor: 6 people, 20.69%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 20.69%
Stress And Anxiety: 5 people, 17.24%
Indigestion: 3 people, 10.34%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.34%
Constipation: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Carvedilol and have Abdominal adhesions?

Check whether Abdominal adhesions is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .

Related studies

How severe was Abdominal adhesions and when was it recovered:

Abdominal adhesions in Carvedilol

Expand to all the drugs that have ingredients of carvedilol:

Abdominal adhesions and drugs with ingredients of carvedilol

Alternative drugs to, pros and cons of Carvedilol:

Carvedilol (97,395 reports)

Common Carvedilol side effects:

Fatigue (feeling of tiredness): 6,610 reports
Breathing difficulty: 6,175 reports
Hypotension (abnormally low blood pressure): 5,548 reports
Diarrhea: 4,974 reports
Dizziness: 4,960 reports
Weakness: 4,730 reports

Browse all side effects of Carvedilol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Abdominal adhesions treatments and more:

Abdominal adhesions (4,177 reports)

COVID vaccines that are related to Abdominal adhesions:

Common drugs associated with Abdominal adhesions:

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol (the active ingredients of Carvedilol) and Carvedilol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.